HAART Aortic Valve Repair Technologies
Resize the aortic valve annulus to reduce dilatation
Reshape the aortic valve to restore more normal, three-dimensional coaptation geometry
Stabilize the aortic valve to reduce the risk of recurrent annular dilatation
Valve Sparing Root
Replacement Simplified
Restores & Stablizes the Annulus
without Root Mobilization

BIOSTABLE Science & Engineering
Simplifying and Standardizing Aortic Valve Repair
Developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.
Read more about our company, management and mission.

Press Release
Press Release — Austin, TX – August 6, 2020 — BioStable Science & Engineering Initiates European Commercialization of the HAART™ 200 Aortic Annuloplasty Device
First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair performed by Professor Marek Jasinski at the Wroclaw Medical University … [Read more]
Press Release — Austin, TX – April 21, 2021 — CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices
The company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve… [Read more]
Press Release — Austin, TX – Feb 25, 2020 — BioStable Science & Engineering Announces Initial Closing of Series C Equity Round
Lead investors Rex Health Ventures and Orlando Health Ventures were joined by Longmeadow Health Care Partners, Santé Health Ventures, Solas BioVentures, and other prior investors … [Read more]